On October 1, Elevance Health fell 3.04% in regular trading, trading at $376.28 USD/share, with Turnover of $34.37 million.
Within the Managed Health Care sector where Elevance Health belongs, the overall sector was broadly under pressure. Among individual stocks, UnitedHealth down 1.01%, Humana down 1.05%, Centene down 3.73%, Molina Healthcare down 4.05%, HealthEquity down 0.43%.
Elevance Health, Inc. is a leading health benefits company operating under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. It serves approximately 104 million consumers through a diversified portfolio spanning medical, pharmacy, behavioral, clinical, and home health solutions across four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company is scheduled to report Q3 earnings on October 21.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)